Treatment of acute promyelocytic leukemia in children: Arsenic or ATRA

Leukemia

Volumn 18, Issue 10, 2004, Pages 1576-1577

  Ravindranath, Y ^a   Gregory, J ^b   Feusner, J ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; CYTARABINE; DAUNORUBICIN; HYBRID PROTEIN; HYDROXYUREA; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA;

ARTICLE; BRAIN PSEUDOTUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CELL STRUCTURE; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CLINICAL TRIAL; CYTOGENETICS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG COST; FOLLOW UP; GENE TRANSLOCATION; HEADACHE; HUMAN; HYPERPIGMENTATION; ICHTHYOSIS; INCIDENCE; INTERMETHOD COMPARISON; LEUKEMIA REMISSION; MONOTHERAPY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; QT PROLONGATION; RETINOIC ACID SYNDROME; STATISTICAL SIGNIFICANCE;

EID: 6344240431     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403479     Document Type: Article

References (12)

1. George BMV, Ponkuzhali B, Shaji RV, Srivastava A, Chandy M. Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience. Leukemia 2004; 18: 1587-1590.
2. de The H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990; 347: 558-561.
3. Chen Z, Guidez F, Rousselot P, Agadir A, Chen SJ, Wang ZY et al. PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc Natl Acad Sci USA 1994; 91: 1178-1182.
4. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 1996; 87: 882-886.
5. Kurian S, Hogan TF, Bleigh OC, Dowdy YG, Merghoub T, Pandolfi PP et al. Atypical t(15;17)(q13;q12) in a patient with all-trans retinoic acid refractory secondary acute promyelocytic leukemia: a case report and review of the literature. Cancer Genet Cytogenet 2002; 138: 143-148.
6. Gregory Jr J, Feusner J. Acute promyelocytic leukaemia in children. Best Pract Res Clin Haematol 2003; 16: 483-494.
7. Rovelli A, Biondi A, Cantu Rajnoldi A, Center V, Giudici G, Jankovic M et al. Microgranular variant of acute promyelocytic leukemia in children. J Clin Oncol 1992; 10: 1413-1418.
8. Biondi A, Rovelli A, Cantu-Rajnoldi A, Fenu S, Basso G, Luciano A et al. Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). Leukemia 1994; 8: 1264-1268.
9. de Botton S, Coiteux V, Chevret S, Rayon C, Vilmer E, Sanz M et al. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol 2004; 22: 1404-1412.
10. Liang DC, Shih LY, Hung IJ, Yang CP, Chen SH, Jaing TH et al. Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia. Cancer 2002; 94: 3292-3298.
11. 3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci USA 2004; 101: 5328-5335.
12. Guillemin MC, Raffoux E, Vitoux D, Kogan S, Soilihi H, Lallemand-Breitenbach V et al. In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. J Exp Med 2002; 196: 1373-1380.